These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Delusions of parasitosis. A dermatologist's guide to diagnosis and treatment. Koo J; Lee CS Am J Clin Dermatol; 2001; 2(5):285-90. PubMed ID: 11721647 [TBL] [Abstract][Full Text] [Related]
9. Crushing deutetrabenazine for treatment of tardive dyskinesia in a patient with severe orofacial symptoms: A case report. Wietholter JP; Sizemore J; Piechowski K Am J Health Syst Pharm; 2020 Sep; 77(18):1477-1481. PubMed ID: 32761113 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Niemann N; Jankovic J Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607 [TBL] [Abstract][Full Text] [Related]
11. Aripiprazole as a viable alternative for treating delusions of parasitosis. Ladizinski B; Busse KL; Bhutani T; Koo JY J Drugs Dermatol; 2010 Dec; 9(12):1531-2. PubMed ID: 21120263 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients. Witter DP; Holbert RC; Suryadevara U Expert Opin Pharmacother; 2017 Jul; 18(10):965-972. PubMed ID: 28443349 [TBL] [Abstract][Full Text] [Related]
13. Valbenazine as the first and only approved treatment for adults with tardive dyskinesia. Sarva H; Henchcliffe C Expert Rev Clin Pharmacol; 2018 Mar; 11(3):209-217. PubMed ID: 29338466 [TBL] [Abstract][Full Text] [Related]
14. Integrative approach for managing tardive dyskinesia: A case report. Kulamarva K; Karanth V; Chikkanna U; Bhargav H; Holla B; Ramakrishna KK; Jasti N; Varambally S Explore (NY); 2023; 19(6):865-867. PubMed ID: 37217392 [TBL] [Abstract][Full Text] [Related]
15. A Focused Update on Tardive Dyskinesia. Blanchet PJ Can J Neurol Sci; 2020 Nov; 47(6):747-755. PubMed ID: 32624027 [TBL] [Abstract][Full Text] [Related]
16. Deutetrabenazine in the treatment of tardive dyskinesia. Niemann N; Jimenez-Shahed J Neurodegener Dis Manag; 2019 Apr; 9(2):59-71. PubMed ID: 30702019 [TBL] [Abstract][Full Text] [Related]
18. Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia. Meyer JM CNS Spectr; 2016 Dec; 21(S1):13-24. PubMed ID: 28044943 [TBL] [Abstract][Full Text] [Related]
19. Tardive Dyskinesia: New Treatments Available. Limandri BJ J Psychosoc Nurs Ment Health Serv; 2019 May; 57(5):11-14. PubMed ID: 31042295 [TBL] [Abstract][Full Text] [Related]
20. VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia. Warren B; Vanderhoef D; Johnson J Issues Ment Health Nurs; 2022 Jan; 43(1):22-31. PubMed ID: 34370608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]